000			01515 a2200397 4500
005			20250518025906.0
264		0	_c20200814
008			202008s 0 0 eng d
022			_a1578-8989
024	7		_a10.1016/j.medcli.2019.01.010 _2doi
040			_aNLM _beng _cNLM
100	1		_aBraga, Beatriz P
245	0	0	_aPneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases. _h[electronic resource]
260			_bMedicina clinica _c06 2019
300			_a502-507 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aArthritis, Rheumatoid _xcomplications
650	0	4	_aAutoimmune Diseases _xcomplications
650	0	4	_aGlucocorticoids _xadverse effects
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunologic Factors _xadverse effects
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aIncidence
650	0	4	_aLupus Erythematosus, Systemic _xcomplications
650	0	4	_aLymphocyte Count
650	0	4	_aPneumocystis carinii
650	0	4	_aPneumonia, Pneumocystis _xepidemiology
650	0	4	_aRituximab _xadverse effects
650	0	4	_aSystemic Vasculitis _xcomplications
700	1		_aPrieto-González, Sergio
700	1		_aHernández-Rodríguez, José
773	0		_tMedicina clinica _gvol. 152 _gno. 12 _gp. 502-507
856	4	0	_uhttps://doi.org/10.1016/j.medcli.2019.01.010 _zAvailable from publisher's website
999			_c29459725 _d29459725